Reduced emergency department use among insured individuals receiving extended-release buprenorphine in a health system setting.

ABSTRACT:

Introduction

Extended-release buprenorphine (XR-Bup) is associated with reduced opioid use and opioid negative urine drug screens. Little is known about its use in outpatient addiction care provided within health systems.

Methods

Individuals prescribed XR-Bup were identified from electronic health records; chart abstraction was conducted. Primary outcome was all-cause emergency department (ED) use. Secondary outcomes included ED use or inpatient stays for mental health or substance use, ED use for any other cause, discontinuation reasons, and drug substitution. Statistical comparisons used nonparametric tests from related samples (McNemar's test and Wilcoxon matched pair tests) to test outcomes six months prior and 6 months following XR-Bup initiation.

Results

152 ind

SUBMITTER: Yarborough BJH 

PROVIDER: S-EPMC11063592 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature